Rashi Krishnan
Overview
Explore the profile of Rashi Krishnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saini C, Zaid G, Gachechiladze L, Krishnan R
Neurol Clin Pract
. 2022 Jun;
12(3):e25-e27.
PMID: 35747548
Objective: COVID-19 infection is suggested as one of the causes for hydrocephalus (HCP) of unknown etiology. COVID-19 infection may present with a range of neurologic symptoms given viral neurotropic and...
2.
Krishnaiah B, Dawkins D, Nguyen V, Ishfaq M, Pandhi A, Krishnan R, et al.
J Stroke Cerebrovasc Dis
. 2022 Jun;
31(8):106602.
PMID: 35724490
Background: Recent extended window trials support the benefit of mechanical thrombectomy in anterior circulation large vessel occlusions with clinical-radiographic dissociation. Using trial imaging criteria, 6% were found eligible for MT...
3.
Kasturiarachi B, Krishnan R, Alsbrook D, Hudson B, Kelly H, Moran C, et al.
Neurohospitalist
. 2022 Apr;
12(2):227-230.
PMID: 35419138
Background: Intravenous (IV) levetiracetam (LEV) is an antiseizure medication traditionally given as an intermittent infusion to mitigate potential adverse effects given its acidic formulation. The process of compounding may lead...
4.
Krishnan R, Mays W, Elijovich L
Neurology
. 2021 Nov;
97(20 Suppl 2):S115-S125.
PMID: 34785610
Multiple randomized clinical trials have supported the use of mechanical thrombectomy (MT) as standard of care in the treatment of large vessel occlusion acute ischemic stroke. Optimal outcomes depend not...
5.
Chang J, Dowlati E, Triano M, Kalegha E, Krishnan R, Kasturiarachi B, et al.
J Stroke Cerebrovasc Dis
. 2021 Jun;
30(9):105936.
PMID: 34174515
Purpose: We sought to evaluate the relationship between admission neutrophil-to-lymphocyte ratio (NLR) and functional outcome in aneurysmal subarachnoid hemorrhage (aSAH) patients. Material And Methods: Consecutive patients with aSAH were treated...
6.
Goyal N, Tsivgoulis G, Chang J, Malhotra K, Goyanes J, Pandhi A, et al.
J Neurointerv Surg
. 2019 Jun;
12(2):142-147.
PMID: 31243068
Introduction: One uncommon complication of mechanical thrombectomy (MT) is an infarct in a new previously unaffected territory (infarct in new territory (INT)). Objective: To evaluate the predictors of INT with...
7.
Goyal N, Tsivgoulis G, Pandhi A, Malhotra K, Krishnan R, Ishfaq M, et al.
J Neurointerv Surg
. 2019 May;
11(11):1073-1079.
PMID: 31088941
Introduction: We sought to evaluate the impact of pretreatment with intravenous thrombolysis (IVT) on the rate and speed of successful reperfusion (SR) in patients with emergent large vessel occlusion (ELVO)...
8.
Qureshi A, Ishfaq A, Ishfaq M, Pandhi A, Ahmed S, Singh S, et al.
J Vasc Interv Neurol
. 2019 Feb;
10(2):33-40.
PMID: 30746008
Objective: To assess the effectiveness of cilostazol, a selective inhibitor of phosphodiesterase type III, in preventing cerebral ischemia related to cerebral vasospasm after aneurysmal subarachnoid hemorrhage (SAH). Methods: A total...
9.
Pour-Ghaz I, Krishnan R, Pierce W, Jackson C, Bhole R, Seth A
Cureus
. 2019 Jan;
10(10):e3525.
PMID: 30648060
Stroke is the second leading cause of death globally and can lead to significant adverse outcomes in patients following the acute illness. Due to this high morbidity and mortality, adequate...
10.
Pandhi A, Tsivgoulis G, Ishfaq M, Katsanos A, Magoufis G, Malhotra K, et al.
J Neurol Sci
. 2018 Nov;
396:193-198.
PMID: 30481657
Objective: Evaluating the safety and efficacy of mechanical thrombectomy (MT) in acute stroke patients due to emergent large vessel occlusion (ELVO) with high international-normalized-ratio (INR). Methods: Consecutive ELVO patients treated...